• Menu
  • Skip to primary navigation
  • Skip to main content

The INTERVAL study

Public Health and Primary Care

Header Left

Interval Study logo, including the words "Interval"

Header Left

Interval Study logo, including the words "Interval"
  • Home
  • About
    • About the study
    • Why is it important?
    • What is involved?
    • Who’s involved?
    • Where?
    • Information leaflet
    • Consent form
    • Electronic Health Record Linkage
  • FAQs
    • INTERVAL Main Results
    • General questions from INTERVAL donors
    • 2-year anniversary measurements
    • Physical Activity measurements
    • INTERVAL Phase II
    • INTERVAL Phase III
    • Accessing Electronic Health Records
  • Physical Activity
  • Phase II & III
    • INTERVAL Phase II
    • INTERVAL Phase III
  • Contact Us
  • Publications
  • News
  • Home
  • About
    • About the study
    • Why is it important?
    • What is involved?
    • Who’s involved?
    • Where?
    • Information leaflet
    • Consent form
    • Electronic Health Record Linkage
  • FAQs
    • INTERVAL Main Results
    • General questions from INTERVAL donors
    • 2-year anniversary measurements
    • Physical Activity measurements
    • INTERVAL Phase II
    • INTERVAL Phase III
    • Accessing Electronic Health Records
  • Physical Activity
  • Phase II & III
    • INTERVAL Phase II
    • INTERVAL Phase III
  • Contact Us
  • Publications
  • News

Welcome

The INTERVAL study has been set up by the Universities of Cambridge and Oxford in collaboration with NHS Blood and Transplant.

We started recruiting blood donors to the study in June 2012 and reached our target of 50,000 study participants two years later, in June 2014. Donors who give blood across England have joined the INTERVAL study to help our researchers compare the effects of donating blood at different time intervals.

Our goal is to find the optimum interval for which it is safe for different donors to give blood. We will look at whether donation intervals should be tailored to donors by age, gender, genetic profile and other characteristics. The study’s findings should help to improve the well-being of blood donors in England and enhance the country’s blood supplies.

Copyright © 2025 · School of Clinical Medicine·University of Cambridge
Freedom of Information . Accessibility . Privacy